Phase 1 – testing safety in a small group of people
Conditions:
Healthy Volunteers - Male and Female
Sponsor: Orna Therapeutics, Inc.
trial.available_in:
БГ
Overview
The purpose of this study is to assess the safety and tolerability of ORN252 in healthy adult participants.
Who can participate
Inclusion Criteria:
* Male and female participants who are healthy as determined by the Investigator based on review of medical history, physical examination, and laboratory tests
* Participant is willing and able to comply with study visits and other protocol requirements
* Other protocol specific inclusion criteria may apply
Exclusion Criteria:
* Clinically significant history or presence of organ dysfunction
* Use of any investigational product within 3 months, or 5 half-lives, whichever longer
* Other protocol specific exclusion criteria may apply
БГ